Matinas Biopharma Holdings Inc. (MTNB) Dipped -11.94% or -0.16 To Price $1.18 On Tuesday


Matinas Biopharma Holdings Inc. (MTNB) dipped -11.94% or -0.16 to $1.18. It is nearly 478873 shares traded, which is 224.04% compare to the average total volume 213742. The market cap of MTNB is $109.68 million. The year to date change is -10.07%. The 52 week price range is from $1.01 to $3.99. Price of MTNB have changed -9.46% during last week. It have changed -0.74% over last month, 5.51% over last 3 months, -33.00% over last 6 months and -4.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 1.28. It is 8.47% above current price. The 200-day Moving Averages for MTNB is 1.90. It is 61.02% above current price. The 52-week High is 3.99. It is 238.14% from the current price. The 52-week Low is 1.01. It is -14.41% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 14.12 on 2017-11-30. Short % to float is 2.34%. There are some statistics of MTNB. It is has market cap $109.68 million. The share outstanding is 92.95 million. The average volume is 213742. The revenue is 104781. It has 40.21M cash and 650577 in debt. The percent of top 15 Institution holding is 8.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -634.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -219.53%.


Tags:

Share this post